Search
Now showing items 1-5 of 5
Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya
(Wiley, 2018)
OBJECTIVES: To assess access to noncommunicable diseases (NCD) medicines in Kenya for patients diagnosed and prescribed treatment for asthma, diabetes and hypertension.
METHODS: Households in eight purposively chosen ...
Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: A cross-sectional survey in eight counties
(BMJ Publishing Group, 2020)
The objective of this study was to determine the availability and prices of medicines for non-communicable diseases (NCDs) in health facilities and private for-profit drug outlets in Kenya. Design Cross-sectional study. ...
Coping with access barriers to non‐ communicable disease medicines: Qualitative patient interviews in eight counties in Kenya
(BMC, 2021)
There is rich literature on barriers to medicines access for the treatment of non-communicable
diseases (NCDs) in high-income countries. Less is known about low- and middle-income countries, in particular the
differences ...
Public reporting on pharmaceutical industry-led access programs: Alignment with the WHO medicine programs evaluation checklist
(Springer Nature, 2020)
There has been increased demand for greater public accountability and transparency of private sector-led global health partnership programs. This study critically reviews and pilot tests the World Health Organization (WHO) ...
Willingness to pay brand premiums for generic medicines in Kenya: A bidding game experiment
(John Wiley and Sons Ltd, 2023)
Background: Recent growth in the market share of higher priced branded generic medicines in low- and middle-income countries (LMICs) has raised concerns around affordability and access. We examined consumer willingness to ...